FLT3 Inhibitor: An Emerging Therapy in Hematological Malignancies
Stagescancer.net – The landscape of leukemia treatment is witnessing a significant shift with the introduction of FLT3 inhibitor therapy, a groundbreaking development in the fight against hematological malignancies. Through targeted approaches that challenge traditional methodologies, FLT3 inhibitors are carving a niche in precision medicine, offering hope to patients with specific genetic mutations associated with aggressive forms of cancer. This…